CA2595485A1 - Compositions liposomiques pour administration parenterale de statines - Google Patents
Compositions liposomiques pour administration parenterale de statines Download PDFInfo
- Publication number
- CA2595485A1 CA2595485A1 CA 2595485 CA2595485A CA2595485A1 CA 2595485 A1 CA2595485 A1 CA 2595485A1 CA 2595485 CA2595485 CA 2595485 CA 2595485 A CA2595485 A CA 2595485A CA 2595485 A1 CA2595485 A1 CA 2595485A1
- Authority
- CA
- Canada
- Prior art keywords
- statin
- liposome
- micelle
- composition
- lipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2595485 CA2595485A1 (fr) | 2007-08-01 | 2007-08-01 | Compositions liposomiques pour administration parenterale de statines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2595485 CA2595485A1 (fr) | 2007-08-01 | 2007-08-01 | Compositions liposomiques pour administration parenterale de statines |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2595485A1 true CA2595485A1 (fr) | 2009-02-01 |
Family
ID=40339614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2595485 Abandoned CA2595485A1 (fr) | 2007-08-01 | 2007-08-01 | Compositions liposomiques pour administration parenterale de statines |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2595485A1 (fr) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104323997A (zh) * | 2010-07-29 | 2015-02-04 | 湖南康都制药有限公司 | 辛伐他汀脂质体组合药物及其大工业化生产工艺和用途 |
WO2018045015A1 (fr) * | 2016-09-01 | 2018-03-08 | Kevin Jon Williams | Procédés et kits pour réduire la tendance de particules de lipoprotéine à l'agrégation athérogène induite par des enzymes de paroi artérielle |
EP3386503A4 (fr) * | 2015-12-10 | 2019-08-07 | Endoperfusion Solutions, LLC | Méthodes et formulations pour le traitement d'une maladie vasculaire |
US10709662B1 (en) | 2020-01-29 | 2020-07-14 | King Abdulaziz University | Mucoadhesive buccal film having a dual release carrier system |
CN114831938A (zh) * | 2022-05-24 | 2022-08-02 | 郑州大学第一附属医院 | 一种包载阿托伐他汀钙的聚合物胶束、制剂及制备方法 |
CN115025242A (zh) * | 2022-05-19 | 2022-09-09 | 南开大学 | 一种他汀前药和他汀靶向递送系统及其制备方法和应用 |
-
2007
- 2007-08-01 CA CA 2595485 patent/CA2595485A1/fr not_active Abandoned
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104323997A (zh) * | 2010-07-29 | 2015-02-04 | 湖南康都制药有限公司 | 辛伐他汀脂质体组合药物及其大工业化生产工艺和用途 |
EP3386503A4 (fr) * | 2015-12-10 | 2019-08-07 | Endoperfusion Solutions, LLC | Méthodes et formulations pour le traitement d'une maladie vasculaire |
WO2018045015A1 (fr) * | 2016-09-01 | 2018-03-08 | Kevin Jon Williams | Procédés et kits pour réduire la tendance de particules de lipoprotéine à l'agrégation athérogène induite par des enzymes de paroi artérielle |
CN109789217A (zh) * | 2016-09-01 | 2019-05-21 | 凯文·乔恩·威廉姆斯 | 用于降低脂蛋白颗粒对动脉壁酶引起的致动脉粥样硬化性聚集的敏感度的方法和试剂盒 |
US10709662B1 (en) | 2020-01-29 | 2020-07-14 | King Abdulaziz University | Mucoadhesive buccal film having a dual release carrier system |
CN115025242A (zh) * | 2022-05-19 | 2022-09-09 | 南开大学 | 一种他汀前药和他汀靶向递送系统及其制备方法和应用 |
CN115025242B (zh) * | 2022-05-19 | 2023-10-20 | 南开大学 | 一种他汀前药和他汀靶向递送系统及其制备方法和应用 |
CN114831938A (zh) * | 2022-05-24 | 2022-08-02 | 郑州大学第一附属医院 | 一种包载阿托伐他汀钙的聚合物胶束、制剂及制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10959951B2 (en) | Pharmaceutical compositions for intraarticular delivery | |
US20080026049A1 (en) | Liposomal compositions for parenteral delivery of agents | |
US20190151243A1 (en) | Composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same | |
JPH10506395A (ja) | 二層安定化成分及びプログラムできる融合性リポソームの形成のためへのそれらの使用 | |
US20170258722A1 (en) | Encapsulating liposomes | |
CA2595485A1 (fr) | Compositions liposomiques pour administration parenterale de statines | |
EP1448165B1 (fr) | Compositions a vecteurs lipidiques et procedes garantissant une meilleure retention medicamenteuse | |
EA018246B1 (ru) | Везикулярные составы, содержащие производные органических кислот, и процесс их приготовления | |
JP2010518012A (ja) | カンプトテシン誘導体を含む医薬組成物 | |
EP1399191A2 (fr) | Agent therapeutique de penetration cellulaire | |
WO2006086992A2 (fr) | Systemes d'apport de medicament contenant des derives de promedicament lipidique degradant la phospholipase a2 et utilisations therapeutiques de ces derniers par exemple en tant qu'agents de guerison des blessures ou en tant que ligands de recepteurs actives par un proliferateur au peroxysome | |
Matole et al. | Need of liposomes as a novel drug delivery system | |
WO2020254633A1 (fr) | Formulation liposomale de doxorubicine, procédé de production d'une formulation liposomale de doxorubicine et utilisation d'une formulation liposomale de doxorubicine en tant que médicament | |
JP3693209B2 (ja) | 閉鎖小胞の製造方法 | |
US20230285293A1 (en) | Pharmaceutical composition of intra-articular corticosteroid for pain control | |
WO2003022250A2 (fr) | Vesicules stabilisees au moyen de polymeres hydrophiles a chaine courte |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |